organophosphonates has been researched along with Kidney Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Churchill, DR; Fitzgerald, N; Gilleece, Y; Hughes, DJ; Konig, M; Moore-Moffatt, R; Sran, H; Webb, A | 1 |
| Altwein, JE; Hoesl, CE | 1 |
| Elson, P; Hsieh, P; Oken, MM; Trump, DL; Witte, RS | 1 |
| Balzarini, J; De Clercq, E; Hatse, S; Naesens, L | 1 |
| Craig, JB; Crawford, ED; Goodman, P; Higano, CS; Kish, JA; Rivkin, SE; Wolf, M | 1 |
| Edeling, CJ | 1 |
1 review(s) available for organophosphonates and Kidney Neoplasms
| Article | Year |
|---|---|
Biphosphonates in advanced prostate and renal cell cancer--current status and potential applications.
Topics: Bone Neoplasms; Disease Progression; Humans; Kidney Neoplasms; Male; Organophosphonates; Prostatic Neoplasms | 2006 |
2 trial(s) available for organophosphonates and Kidney Neoplasms
| Article | Year |
|---|---|
A phase II trial of amonafide, caracemide, and homoharringtonine in the treatment of patients with advanced renal cell cancer.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Harringtonines; Homoharringtonine; Humans; Hydroxyurea; Imides; Isoquinolines; Kidney Neoplasms; Male; Middle Aged; Naphthalimides; Organophosphonates; Survival Rate; Treatment Outcome | 1996 |
Phase II evaluation of amonafide in renal cell carcinoma. A Southwest Oncology Group study.
Topics: Adenine; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Evaluation; Female; Humans; Imides; Isoquinolines; Kidney Neoplasms; Male; Middle Aged; Naphthalimides; Organophosphonates | 1991 |
3 other study(ies) available for organophosphonates and Kidney Neoplasms
| Article | Year |
|---|---|
Acute kidney injury as a presentation of primary renal diffuse large B-cell lymphoma in HIV.
Topics: Acute Kidney Injury; Adenine; Adult; Anti-HIV Agents; Antinematodal Agents; Biopsy; HIV Infections; Humans; Kidney; Kidney Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Organophosphonates; Tenofovir; Treatment Outcome | 2014 |
Potent differentiation-inducing properties of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in the rat choriocarcinoma (RCHO) tumor cell model.
Topics: Adenine; Alkaline Phosphatase; Animals; Antigens, Neoplasm; Antigens, Surface; Antiviral Agents; Cell Differentiation; Cell Survival; Choriocarcinoma; Drug Therapy, Combination; Enzyme Induction; Growth Inhibitors; Kidney Neoplasms; Methotrexate; Organophosphonates; Organophosphorus Compounds; Progesterone; Rats; Rats, Inbred Strains; Rats, Wistar; Retroviridae; Tenofovir; Trophoblasts; Tumor Cells, Cultured | 1998 |
Bone scintigraphy with 99mTc-labelled polyphosphate.
Topics: Adenocarcinoma; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Female; Fibrous Dysplasia of Bone; Hodgkin Disease; Humans; Injections, Intravenous; Kidney Failure, Chronic; Kidney Neoplasms; Kidney Transplantation; Lung Neoplasms; Male; Neoplasm Metastasis; Organophosphonates; Organophosphorus Compounds; Osteitis Deformans; Phosphates; Prostatic Neoplasms; Radionuclide Imaging; Spinal Neoplasms; Technetium | 1974 |